Myelophthistic anemia: Difference between revisions

m (Rossdonaldson1 moved page Myelophthistic Anemia to Myelophthistic anemia)
No edit summary
 
(9 intermediate revisions by 5 users not shown)
Line 1: Line 1:
==Background==
==Background==
*Form of normocytic anemia
*Form of normocytic [[anemia]]
*Infiltrative disorder of bone marrow in the setting of malignancy--invasive tumor, leukemia, lymphoma, granuloma
*Associated with infiltrative disorder or bone marrow in the setting of malignancy--[[leukemia]], [[lymphoma]], granuloma


==Clinical Features==
==Clinical Features==
*Most pts begin to be symptomatic at ~7gm/dL
*[[Anemia]] in patient with history of malignancy
*Weakness, fatigue, lethargy, DOE, palpitations
*Pale skin
*Skin, nail bed, mucosal pallor
*[[Tachycardia]]/[[hypotension]] in severe cases
*Widened pulse pressure
*[[hepatomegaly|Hepatosplenomegaly]] as sign of extra medullary hematopoiesis
*Tachycardia/hypotension in severe cases
*Hepatosplenomegaly as sign of extra medullary hematopoiesis


==Differential Diagnosis==
==Differential Diagnosis==
*Aplastic anemia
*[[Aplastic anemia]]
*Myelofibrosis
*[[Myelofibrosis]]
*Acute blood loss anemia
*[[hemorrhage|Acute blood]] loss anemia
*Bone marrow suppression
*Bone marrow suppression
*Anemia of chronic disease
*Anemia of chronic disease
*Hemolytic anemia
*[[Hemolytic anemia]]


==Diagnosis==
==Evaluation==
*Requires bone marrow biopsy
*Requires bone marrow biopsy
*Labs show normocytic anemia with decreased reticulocyte count
*Labs show normocytic anemia with decreased reticulocyte count
*Exam with signs of extra medullary hematopoiesis
*Exam with signs of extra medullary hematopoiesis
*Index of suspicion in setting of malignancy + anemia
*Index of suspicion in setting of malignancy


==Management==
==Management==
*Identify anemia as emergent or non-emergent
*Identify anemia as emergent or non-emergent
*Evaluate for superimposed etiologies of anemia (Ie acute blood loss) and target treatment in the ED
*Evaluate for superimposed etiologies of anemia (Ie acute blood loss) and target treatment in the ED
*If emergent anemia get IV access, transfuse for signs of end organ damage--AMS, hypotension, chest pain, shortness of breath, decreased UOP
*If emergent anemia get IV access, [[pRBCs|transfuse]] for signs of end organ damage--altered mental status, hypotension, chest pain, shortness of breath, decreased UOP
*Will need treatment of underlying malignancy to allow marrow recovery while supporting hemodynamics
*Will need treatment of underlying malignancy to allow marrow recovery while supporting hemodynamics


Line 36: Line 34:
==See Also==
==See Also==
*[[Anemia]]
*[[Anemia]]
*[[Transfusions]]
==External Links==


==References==
==References==
*Rosen, Peter, John A. Marx, Robert S. Hockberger, and Ron M. Walls. "Anemia". Rosen's Emergency Medicine Concepts and Clinical Practice. 8th ed. Vol. 2. Philadelphia, PA: Elsevier/Saunders, 2013.
<references/>
<references/>
[[Category:Heme/Onc]]

Latest revision as of 05:00, 1 October 2019

Background

  • Form of normocytic anemia
  • Associated with infiltrative disorder or bone marrow in the setting of malignancy--leukemia, lymphoma, granuloma

Clinical Features

Differential Diagnosis

Evaluation

  • Requires bone marrow biopsy
  • Labs show normocytic anemia with decreased reticulocyte count
  • Exam with signs of extra medullary hematopoiesis
  • Index of suspicion in setting of malignancy

Management

  • Identify anemia as emergent or non-emergent
  • Evaluate for superimposed etiologies of anemia (Ie acute blood loss) and target treatment in the ED
  • If emergent anemia get IV access, transfuse for signs of end organ damage--altered mental status, hypotension, chest pain, shortness of breath, decreased UOP
  • Will need treatment of underlying malignancy to allow marrow recovery while supporting hemodynamics

Disposition

  • Admit for bone marrow biopsy and treatment of underlying disease

See Also

References

  • Rosen, Peter, John A. Marx, Robert S. Hockberger, and Ron M. Walls. "Anemia". Rosen's Emergency Medicine Concepts and Clinical Practice. 8th ed. Vol. 2. Philadelphia, PA: Elsevier/Saunders, 2013.